Inari Medical Stock Beta
| NARIDelisted Stock | USD 79.97 0.00 0.00% |
Inari Medical fundamentals help investors to digest information that contributes to Inari Medical's financial success or failures. It also enables traders to predict the movement of Inari Stock. The fundamental analysis module provides a way to measure Inari Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inari Medical stock.
Inari |
Inari Medical Company Beta Analysis
Inari Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Inari Medical Beta | 1.03 |
Most of Inari Medical's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inari Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Inari Medical has a Beta of 1.028. This is 19.53% higher than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 1.04) industry. The beta for all United States stocks is notably lower than that of the firm.
Inari Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inari Medical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inari Medical could also be used in its relative valuation, which is a method of valuing Inari Medical by comparing valuation metrics of similar companies.Inari Medical is currently under evaluation in beta category among its peers.
Inari Medical returns are very sensitive to returns on the market. As the market goes up or down, Inari Medical is expected to follow.
Inari Fundamentals
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.0321 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 4.6 B | ||||
| Shares Outstanding | 58.56 M | ||||
| Shares Owned By Insiders | 8.99 % | ||||
| Shares Owned By Institutions | 95.50 % | ||||
| Number Of Shares Shorted | 2.48 M | ||||
| Price To Earning | 275.35 X | ||||
| Price To Book | 10.77 X | ||||
| Price To Sales | 8.15 X | ||||
| Revenue | 493.63 M | ||||
| Gross Profit | 498.76 M | ||||
| EBITDA | 15.19 M | ||||
| Net Income | (1.64 M) | ||||
| Cash And Equivalents | 330.5 M | ||||
| Cash Per Share | 6.19 X | ||||
| Total Debt | 32.05 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 10.04 X | ||||
| Book Value Per Share | 7.44 X | ||||
| Cash Flow From Operations | 35.93 M | ||||
| Short Ratio | 0.54 X | ||||
| Earnings Per Share | (1.35) X | ||||
| Price To Earnings To Growth | (1.88) X | ||||
| Target Price | 78.03 | ||||
| Number Of Employees | 1.3 K | ||||
| Beta | 1.03 | ||||
| Market Capitalization | 4.68 B | ||||
| Total Asset | 674.24 M | ||||
| Retained Earnings | (48.49 M) | ||||
| Working Capital | 159.22 M | ||||
| Net Asset | 674.24 M |
About Inari Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inari Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inari Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inari Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Inari Stock
If you are still planning to invest in Inari Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Inari Medical's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |